HMG-CoA Reductase Inhibitor [EPC]

291284 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 15049
1 NAUSEA 14607
2 DRUG INEFFECTIVE 14288
3 DYSPNOEA 13909
4 DIARRHOEA 12717
5 DIZZINESS 12410
6 ASTHENIA 10563
7 PAIN 10206
8 MYALGIA 10096
9 FALL 9977
See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED NECROTISING MYOPATHY 257 0.4565
1 MYOPATHY 1494 0.2580
2 RHABDOMYOLYSIS 6471 0.2273
3 HYPERPARATHYROIDISM SECONDARY 390 0.2270
4 NEPHROGENIC ANAEMIA 703 0.2189
5 REBOUND ACID HYPERSECRETION 431 0.1665
6 MYOSITIS 821 0.1565
7 POLYMYOSITIS 191 0.1549
8 SELF ESTEEM DECREASED 186 0.1523
9 BLOOD CREATINE PHOSPHOKINASE INCREASED 2967 0.1338
See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]